WednesdayNov 20, 2019 4:00 pm

Company Teams Up With Florida State University to Study Painkilling Effects of CBD

CBD, or cannabidiol, as the nerds call it is a hemp extract that has completely taken the world by storm. The compound is said to be effective against a variety of medical conditions, ranging from insomnia to chronic pain and high blood pressure. In June 2018, the FDA approved a CBD-based drug to treat epilepsy-related seizures in children. 14% of all Americans use CBD, and roughly 40% of these users do it for pain relief. Arguably, there has been a lot of interest in cannabidiol's anti-inflammatory properties, especially as an alternative to opiates. A leading hemp research company is looking…

Continue Reading

WednesdayNov 20, 2019 1:46 pm

MCTC Holdings Inc. (MCTC) Advances Cannabinoid Delivery Research Efforts, Files Fourth High-Tech Patent

Most significant patent filed is also the most comprehensive, covering broad areas of cannabinoid polymeric nanoparticles and fibers Company is committed to continuing research program and expand its intellectual property portfolio over the coming months MCTC participating in multiple growing verticals within global cannabis industry through acquisitions, strategic partnerships, and intellectual property MCTC Holdings Inc. (OTC: MCTC), a cannabinoid science innovator focused on high-growth and high-margins sub-sectors of the cannabis and hemp industry, filed its fourth cannabinoid delivery technology patent. The patent broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially…

Continue Reading

WednesdayNov 20, 2019 11:55 am

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces Appointment of Ecommerce Exec to Board of Directors

Former Head of Digital Commerce at HSN, Jill Braff brings a wealth of experience in marketing, e-commerce to her new role CEO believes PLUS online CBD business will be transformative for the company Braff deems PLUS one of most promising companies in a high-growth industry Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis-branded product company with the two best-selling cannabis products in California, recently announced the appointment of ecommerce senior executive Jill Braff to the company’s board of directors (http://cnw.fm/Hr3iT). The move is aimed at further strengthening the company’s already impressive digital sales and marketing expertise. “We couldn’t be…

Continue Reading

WednesdayNov 20, 2019 9:00 am

CBD Helps Connecticut Chiropractor With Lyme Disease To Quit OTC Medications

If you haven't been living under a rock for the past few years, you have undoubtedly heard about cannabidiol (CBD). The cannabis extract has been impressing consumers with its medicinal properties, and it is set to be one of, if not the most, versatile medicines of the century. The compound has been found effective against a host of conditions ranging from chronic pain to seizures in rare childhood epilepsies. At least 40% of the people who use CBD do so for pain relief. Gene Gresh, a compounding pharmacist, says, "Anecdotally, we see amazing pain relief qualities when it's used topically.…

Continue Reading

TuesdayNov 19, 2019 4:00 pm

Industry Upset as Germany Classifies CBD as a Novel Food

The hemp sector in Germany has been left in a bind after the country's federal government recently confirmed that cannabidiol (CBD) is to be classified as a novel food. Entities interested in selling CBD products will have to apply for marketing authorization before sending their products into the market, a tedious and expensive process. A novel food is a type of food that doesn't have much history of consumption or is produced through previously unused methods. European Union (EU) regulations state that “any food that was not consumed significantly before March 1997 is considered a novel food. The category covers…

Continue Reading

TuesdayNov 19, 2019 10:07 am

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Focused on Owning Branded-CBD Space

Plus Products’ focused on edible cannabis-infused products Company has dedicated food manufacturing facility in California PLUS product family includes newly launched CBD-infused gummies Focusing on offering a consistent cannabis experience, Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) produces edibles using extracts to ensure compliant, dosable and flavorful products supporting a healthy and active lifestyle. Headquartered in San Mateo, California, the company is fundamentally a branded, cannabis-infused products manufacturer, offering the #1 best-selling Cannabis products in California according to BDS Analytics. The company’s product team consists of chefs, chemists, food-manufacturing experts. A hemp-and-cannabis food company, Plus Products’ emphasis is on thoughtfully…

Continue Reading

TuesdayNov 19, 2019 9:00 am

New Jersey Senate Passes Bill Urging Feds to Enact CBD Dosage Guidelines

The hemp industry has been through a rollercoaster of legislation over the past few years. First, the 2018 Farm Bill made the cultivation of industrial hemp legal, and by extension, making the marketing and sale of hemp-derived CBD legal. This was followed by the USDA's interim rule on hemp in October 2019 which provided a regulatory framework for the rapidly growing sector. However, one issue that still plagues the industry is the lack of regulation for CBD products. For long, major players in the industry and other interested parties have decried the lack of control for CBD products, stating that…

Continue Reading

MondayNov 18, 2019 4:00 pm

Another Study Shows CBD Can Reduce Opioid Use

If you haven’t been living under a rock for the past few years, you have undoubtedly heard about cannabidiol (CBD). The cannabis extract has been having quite the magnificent run, with the CBD industry expected to be worth $20 billion by 2024. This growth is due to the compound’s insane potency and versatility as a medicine, with users saying CBD gave them relief from a variety of diseases ranging from high blood pressure to seizures in rare childhood epilepsies. Chronic pain relief is by far the most common issue CBD users seek to address, and a new study has produced…

Continue Reading

MondayNov 18, 2019 9:00 am

Cannabidiol Can Help to Manage Endometriosis Pain, New Study

Cannabidiol (CBD) is a cannabis extract with remarkable medicinal properties, and for the past few years, it has kept the world enthralled. It is often confused for THC (delta-9 tetrahydrocannabinol), the component responsible for cannabis's famous high, but CBD is non-psychoactive, and it doesn't make users high. Instead, the compound acts as a potent and versatile medicine, working against a variety of conditions ranging from anxiety and high blood pressure to chronic pain and rare childhood epilepsies. However, it has only been researched to a limited degree, and there is still a lot about CBD that we still don’t know.…

Continue Reading

FridayNov 15, 2019 4:00 pm

Survey Shows Americans Think the FDA Regulates the CBD Industry

The cannabidiol (CBD) issue is quite a divisive one. The cannabis extract has come from obscurity to an insane level of fame in a surprisingly short time. In 2018, it was the third most searched for item in the US, and the sector is expected to undergo further growth in the coming years. However, despite CBD's staggering popularity, it turns out that a large percentage of Americans are unbelievably misinformed about crucial aspects of CBD. A survey by US-based Grocery Manufacturers Association (GMA) found that roughly three-quarters of Americans falsely believe that the U.S. Food and Drug Administration regulates and…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722